Evidence map›Paper›PMID 42629475›Full record

ReviewNature reviews. Microbiology2026

Metabolic strategies of Enterobacteriaceae gut colonization.

Christopher Schubert, Wolf-Dietrich Hardt

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christopher SchubertInstitute of Microbiology, Department of Biology, ETH Zurich, Zurich, Switzerland. cschubert@ethz.ch.ORCID http://orcid.org/0000-0002-7921-1470
Wolf-Dietrich HardtInstitute of Microbiology, Department of Biology, ETH Zurich, Zurich, Switzerland. wolf-dietrich.hardt@micro.biol.ethz.ch.ORCID http://orcid.org/0000-0002-9892-6420

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enterobacteriaceae are facultative anaerobic bacteria that commonly colonize the gut and include both commensals and diverse pathogens. They can flexibly adapt their metabolic strategy to grow in the intestinal environment. As Enterobacteriaceae blooms are linked to enteric disease and the dissemination of antibiotic resistance, a deeper understanding of the factors that drive their expansion is needed. In the healthy intestine, Enterobacteriaceae subsist on low concentrations of diet-derived and mucus-derived monosaccharides that feed glycolysis and mixed-acid fermentation. Inflammation reshapes this niche as immune-derived oxidants generate new terminal electron acceptors, such as nitrate or tetrathionate, and facilitate oxygen diffusion into the gut lumen, thereby expanding facultative anaerobes and broadening the range of usable substrates. In this Review, we discuss recent evidence across Escherichia coli, Citrobacter rodentium, Klebsiella spp. and Salmonella Typhimurium to define a conserved, monosaccharide-fuelled programme for colonization and its inflammatory remodelling. Competition with commensal bacteria for these nutrients underpins colonization resistance, and genetic differences can determine competitive fitness. Metabolism lies at the core of these ecological dynamics, and recognizing its central role will help guide the design of future therapies.

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.